Outcomes of graft angiography with distal radial access: a retrospective cohort study.

IF 1.6 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

Future cardiology Pub Date : 2024-01-01 Epub Date: 2024-07-15 DOI:10.1080/14796678.2024.2373592

Hamid Iqbal, Fnu Manoj Kumar, Farrukh Mehmood, Fnu Kiran, Kajal Bai, Kajal Kumari, Fnu Suman, Deepak Kumar, Deepa Rani, Saroop Kumar Alies Rahol Rai, Jahanzeb Malik, Waheed Akhtar

{"title":"Outcomes of graft angiography with distal radial access: a retrospective cohort study.","authors":"Hamid Iqbal, Fnu Manoj Kumar, Farrukh Mehmood, Fnu Kiran, Kajal Bai, Kajal Kumari, Fnu Suman, Deepak Kumar, Deepa Rani, Saroop Kumar Alies Rahol Rai, Jahanzeb Malik, Waheed Akhtar","doi":"10.1080/14796678.2024.2373592","DOIUrl":null,"url":null,"abstract":"Background: This retrospective cohort study aimed to compare the outcomes of graft angiography using these two approaches.Methods: Medical records and angiographic data of adult patients who underwent graft angiography between January 2020 and December 2022 were analyzed.Results: The study included 452 patients in the distal radial access (DRA) group and 960 patients in the femoral access group. Angiographic characteristics showed a higher prevalence of triple vessel disease in the femoral access group (29.8% vs. 20.8%; p = 0.012). The DRA group had a procedural success rate of 93.0%, while the femoral access group had a higher success rate of 95.8%. The odds ratio was 0.66 (95% CI: 0.46-0.94), indicating lower odds of procedural success in the DRA group.Conclusion: Our study suggests that both DRA and femoral access are effective and safe approaches for graft angiography after coronary artery bypass surgery.","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":" ","pages":"479-484"},"PeriodicalIF":1.6000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11486300/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future cardiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/14796678.2024.2373592","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/15 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}

引用次数: 0

Abstract

Background: This retrospective cohort study aimed to compare the outcomes of graft angiography using these two approaches.Methods: Medical records and angiographic data of adult patients who underwent graft angiography between January 2020 and December 2022 were analyzed.Results: The study included 452 patients in the distal radial access (DRA) group and 960 patients in the femoral access group. Angiographic characteristics showed a higher prevalence of triple vessel disease in the femoral access group (29.8% vs. 20.8%; p = 0.012). The DRA group had a procedural success rate of 93.0%, while the femoral access group had a higher success rate of 95.8%. The odds ratio was 0.66 (95% CI: 0.46-0.94), indicating lower odds of procedural success in the DRA group.Conclusion: Our study suggests that both DRA and femoral access are effective and safe approaches for graft angiography after coronary artery bypass surgery.

查看原文本刊更多论文

使用桡动脉远端入路进行移植血管造影的结果：一项回顾性队列研究。

背景：这项回顾性队列研究旨在比较使用这两种方法进行移植血管造影的结果。研究方法分析了 2020 年 1 月至 2022 年 12 月期间接受移植物血管造影术的成年患者的病历和血管造影数据。结果研究包括 452 名桡动脉远端入路（DRA）组患者和 960 名股动脉入路组患者。血管造影特征显示，股动脉入路组三血管疾病的发生率更高（29.8% 对 20.8%；P = 0.012）。DRA 组的手术成功率为 93.0%，而股骨入路组的成功率更高，为 95.8%。几率比为 0.66（95% CI：0.46-0.94），表明 DRA 组的手术成功率较低。结论我们的研究表明，DRA 和股动脉入路都是冠状动脉搭桥手术后进行移植血管造影的有效且安全的方法。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Future cardiology CARDIAC & CARDIOVASCULAR SYSTEMS-

CiteScore

2.80

自引率

5.90%

发文量

期刊介绍： Research advances have contributed to improved outcomes across all specialties, but the rate of advancement in cardiology has been exceptional. Concurrently, the population of patients with cardiac conditions continues to grow and greater public awareness has increased patients" expectations of new drugs and devices. Future Cardiology (ISSN 1479-6678) reflects this new era of cardiology and highlights the new molecular approach to advancing cardiovascular therapy. Coverage will also reflect the major technological advances in bioengineering in cardiology in terms of advanced and robust devices, miniaturization, imaging, system modeling and information management issues.